Qiang Zhao
Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, China · Ruijin Hospital · Tianjin Medical University Cancer Institute and Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Qiang Zhao as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:50 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT06802926 · Pilot Trial of Colchicine for Graft Failure in CABGRuijin Hospital · active not recruiting · CABG, Graft Failure, Colchicine · study chair
- Ph4NCT06730945 · Effect of Oral Isosorbide Mononitrate Plus Amlodipine Antispasm Therapy on Outcomes of Radial Artery Grafts After CABGRuijin Hospital · withdrawn · Coronary Artery Bypass Graft Surgery (CABG), Radial Artery Grafts, Graft Failure · principal investigator
- Early Ph1NCT06621576 · First-in-Human Pilot Study of Epicardial Circular RNA-HM2002 Injection in CABG for Ischemic Heart FailureRuijin Hospital · completed · Ischaemic Heart Disease, Heart Failure · principal investigator
- Ph1NCT05562024 · TAA06 Injection in the Treatment of Patients With B7-H3-positive Relapsed/ Refractory NeuroblastomaPersonGen BioTherapeutics (Suzhou) Co., Ltd. · recruiting · B7-H3-positive Relapsed/ Refractory Neuroblastoma · principal investigator
- N/ANCT05556590 · Quantitative Flow Ratio on Radial Artery Graft Outcome After Coronary Artery Bypass GraftingRuijin Hospital · completed · Coronary Artery Disease · principal investigator
- N/ANCT05036044 · Stroke and Carotid-Cerebral Vascular Disease After CABGRuijin Hospital · completed · Coronary Artery Bypass · principal investigator
- N/ANCT04935086 · Risk Factors for Predictors of MACEs After RA-CABGRuijin Hospital · completed · Coronary Artery Disease · principal investigator
- Ph4NCT04310995 · Different Anti-Spastic Therapy Strategies After CABG Using Radial Artery GraftsRuijin Hospital · completed · Coronary Artery Bypass Graft, Radial Artery Grafts, Antispastic Therapy · principal investigator
- N/ANCT03987373 · DACAB Trial: Follow-up ExtensionRuijin Hospital · completed · Coronary Artery Bypass Grafting, Antiplatelet Therapy · principal investigator
- N/ANCT03977129 · Quantitative Flow Ratio (QFR) Guided Coronary Artery Bypass Grafting for Patients Undergoing Primary Valve Surgery With Concomitant Coronary Artery DiseaseRuijin Hospital · active not recruiting · Primary Valvular Heart Disease With Comorbid Coronary Artery Disease, Planned to Undergo Elective On-pump Valve Surgery Due to Primary Mitral and/or Aortic Valvular Heart Disease · principal investigator
- Ph4NCT03908593 · Proton Pump Inhibitor Preventing Upper Gastrointestinal Injury In Patients On Dual Antiplatelet Therapy After CABGRuijin Hospital · unknown · Gastrointestinal Ulcer (Peptic) or Erosion, Anti-Platelet Therapy, Coronary Artery Bypass · principal investigator
- Ph4NCT02201771 · Different Antiplatelet Therapy Strategy After Coronary Artery Bypass Graft SurgeryRuijin Hospital · completed · Coronary Artery Bypass, Antiplatelet Agents · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:50 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:50 UTC. The ranking covers the 200 most relevant of 438 PubMed records, and a shared surname and initials can bring in a namesake. All 438 on PubMed
- Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001.Ann Oncol · 2019771 citationsRCR 27.0
- Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma.Nat Mater · 2017703 citationsRCR 23.2
- A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma.Nat Med · 2019596 citationsRCR 17.6
- Continuation and satisfaction of reversible contraception.Obstet Gynecol · 2011419 citationsRCR 17.9
- Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis.Gastroenterology · 2020373 citationsRCR 22.1
- Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma.Nat Med · 2019280 citationsRCR 8.6
- 203 citationsRCR 7.1
- 188 citationsRCR 17.5
- A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer's dementia.Alzheimers Res Ther · 2021172 citationsRCR 11.3
- Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial.Nat Med · 2024171 citationsRCR 18.7